ema prac naion semaglutide The use of medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION) European Medicines Agency Investigating GLP-1

A study, by Michael Nauck and colleagues from Bad Lauterberg im Harz, Germany, suggests that taspoglutide (R1583), a long-acting (once-weekly) human glucagon-like peptide-1 (GLP-1) analogue, currently under investigation by Roche for the treatment of type 2 diabetes mellitus, may likewise promote modest weight loss (Diabetes Care)

This whole parallel supply chain that seemingly sprang up overnight was supposed to be temporary, while there's a shortage

Both patterns are normal and typically resolve within 2 to 4 weeks

Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors, working through two hormonal pathways instead of just one